Evidence map›Paper›PMID 36506824›Full record

ArticleContemporary clinical trials communications2022

The combination of isomalto-oligosaccharides (IMO)-based dietary fiber and hypocaloric high-protein diet could improve the anthropometric profile and fasting plasma glucose of healthy adults: A repeated single-arm clinical trial.

Hendy Wijaya, Yu Hirata, Lidya Handayani Tjan, Yudy Tjahjono, Kuncoro Foe, Caroline, Diga Albrian Setiadi, Hevi Wihadmadyatami, Bernadette Dian Novita, Fx Himawan Haryanto Jong and 1 more

Open access · goldAbstract read
In one paragraph

Article in Contemporary clinical trials communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Hendy WijayaBiomedical Laboratory, Faculty of Pharmacy, Widya Mandala Catholic University Surabaya, Jl. Kalisari Selatan No.1, Kalisari, Mulyorejo, Surabaya, East Java, 60112, Indonesia.
Yu HirataDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Lidya Handayani TjanDepartment of Biomedic, School of Medicine, Universitas Ciputra, CitraLand CBD Boulevard, Surabaya, East Java, 60219, Indonesia.
Yudy TjahjonoBiomedical Laboratory, Faculty of Pharmacy, Widya Mandala Catholic University Surabaya, Jl. Kalisari Selatan No.1, Kalisari, Mulyorejo, Surabaya, East Java, 60112, Indonesia.
Kuncoro FoeBiomedical Laboratory, Faculty of Pharmacy, Widya Mandala Catholic University Surabaya, Jl. Kalisari Selatan No.1, Kalisari, Mulyorejo, Surabaya, East Java, 60112, Indonesia.
CarolineBiomedical Laboratory, Faculty of Pharmacy, Widya Mandala Catholic University Surabaya, Jl. Kalisari Selatan No.1, Kalisari, Mulyorejo, Surabaya, East Java, 60112, Indonesia.
Diga Albrian SetiadiBiomedical Laboratory, Faculty of Pharmacy, Widya Mandala Catholic University Surabaya, Jl. Kalisari Selatan No.1, Kalisari, Mulyorejo, Surabaya, East Java, 60112, Indonesia.
Hevi WihadmadyatamiDepartment of Anatomy, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Jl. Fauna 2, Sleman, Yogyakarta, 55281, Indonesia.
Bernadette Dian NovitaFaculty of Medicine, Widya Mandala Surabaya Catholic University, Jl. Kalisari Selatan No.1, Kalisari, Mulyorejo, Surabaya, East Java, 60112, Indonesia.
Fx Himawan Haryanto JongFaculty of Medicine, Widya Mandala Surabaya Catholic University, Jl. Kalisari Selatan No.1, Kalisari, Mulyorejo, Surabaya, East Java, 60112, Indonesia.
Wilson Christianto KhudratiFaculty of Medicine, Widya Mandala Surabaya Catholic University, Jl. Kalisari Selatan No.1, Kalisari, Mulyorejo, Surabaya, East Java, 60112, Indonesia.
Universitas Katolik Widya Mandala Surabaya · IDKobe University · JPUniversitas Ciputra · IDUniversitas Gadjah Mada · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: Meals with high protein and fiber could reduce weight and improve diabetes risk factors. Isomalto-oligosaccharide (IMO), a form of dietary fiber, could induce the afferent signal that causes appetite suppression. However, the direct effect of fiber supplementation in the form of IMO combined with a high-protein diet (HPF) on those parameters is still unknown. This study aims to investigate the effect of HPF on anthropometric parameters and blood glucose regulation of healthy subjects. 
. Methods: Thirteen healthy subjects were given a hypocaloric high protein diet (HPD) mixed with their prepared meals for two weeks. Followed by the HPF diet for another two weeks. Their anthropometric parameters, such as body composition (total body weight, body fat percentage, and fat-free mass), BMI and waist circumference, and fasting plasma glucose, were measured. Results: Compared to pre-intervention, HPF could significantly (p ≤ 0.004) reduce the anthropometric parameters and fasting plasma glucose. Compared to HPD, HPF could significantly (p ≤ 0.005) reduce more total body weight, body fat percentage, and BMI. In addition, HPF could induce more satiety than HPD (higher VAS score). Conclusion: HPF could improve the subject's anthropometric parameters which is obviously beneficial in preventing the risk of developing diabetes.

Indexed as

Blood glucoseBody compositionDiabetesDietary fiber

Identifiers

PMID36506824
PMCPMC9731841
OpenAlexW4310717559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.